YB
BannerBanner

PCT IGF-1

Author
crazymatt
Olympian Member
  • Total Posts : 770
  • Reward points: 4700
  • Joined: 2005/10/11 00:39:11
  • Location: Cheshire
  • Status: offline
2007/06/17 22:32:59 (permalink)
0

PCT IGF-1

just wondering whether this would be a good idea, i must say im finding it very difficult to get information on the stuff, i presume cos its new people are still quite divided on doses.

here what ive come up with

25mg injected bi-laterally into lagging muscle's, post work out 3 times pw for 8-10 weeks.

any input?

the gym is like women - takes up all your time, energy and money if you let it.
#1

3 Replies Related Threads

    dig
    Pro-Member
    • Total Posts : 4333
    • Reward points: 6229
    • Joined: 2006/12/15 21:47:31
    • Location: scotland
    • Status: offline
    RE: PCT IGF-1 2007/06/17 22:42:10 (permalink)
    0
    i think the more common use is starting at 40mcg pwo upping dose if required. in muscle group trained

    for 4 weeks during pct.
    #2
    Baywatch
    Pro-Member
    • Total Posts : 7684
    • Reward points: 7605
    • Joined: 2004/02/15 19:18:00
    • Location: UK
    • Status: offline
    RE: PCT IGF-1 2007/06/17 22:54:27 (permalink)
    0
    50mcg, 5 on, 2 off.. whats how i would do it

    1mg will last you 4 weeks then, 4 weeks is pretty much the common duration on igf
    #3
    pscarb
    Olympian Member
    • Total Posts : 859
    • Reward points: 5754
    • Joined: 2005/09/25 13:33:47
    • Status: offline
    RE: PCT IGF-1 2007/06/17 23:51:06 (permalink)
    0
    as for not finding info on IGF-1LR3 then you cannot be using a search engine as this stuff is every where.....

    I am trialinga new method for my PCT which starts in 1 week which is a higher dose 2on 2off...this should get round the saturation issue that you come up against using the ed method only time will tell
    #4
    Jump to:
    ©2018 All content is copyright of MuscleTalk.co.uk and its use elsewhere is prohibited.
    (posting guidelines | privacy | advertise | earnings disclaimer | contact us | supported by)
    © 2018 APG vNext Commercial Version 5.5